Management of Breast Cancer-Related Lymphedema

Lymphedema is one of the most common complications to occur after breast cancer treatment. It is an important problem that affects individuals' lifestyles and activities, causing physical and psychosocial problems, and negatively affecting quality of life. Treatment of lymphedema was thought to be impossible in the past, but it has now become possible to manage the condition more effectively with current treatment methods. Nurses, who are important members of the healthcare team, play a key role in helping patients to take responsibility and play an active part in the prevention, management, and follow-up of lymphedema. Nurses should be able to identify patients at high risk for developing lymphedema, provide the necessary training for lymphedema prevention, evaluate lymphedema, and plan for appropriate nursing interventions in the early stages. This literature review aims to inform nurses and other healthcare professionals about lymphedema management.

PDF

___

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Harris SR, Hugi RM, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer. 11. Lymphedema. CMAJ 2001;164(2):191-9.
3. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc 2005;80(11):1480-4.
4. Baron RH. Surgical management of breast cancer. Semin Oncol Nurs 2007;23(1):10-9.
5. Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 2006;4(8):381-6.
6. Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR. Exercise for women with or at risk for breast cancer-related lymphedema. Phys Ther 2006;86(10):1398-405.
7. Mortimer PS, Bates DO, Brassington HD, Stanton AWB, Strachan DP, Levick JR. The prevalence of arm oedema following treatment for breast cancer. QJ Med 1996;89(5):377-80.
8. Petrek JA, Heelan MC. Incidence of breast carcinoma- related lymphedema. Cancer 1998;83(S12B):2776-81
9. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001;92(7):1783-7.
10.Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;92(6):1368-77.
11.Tsai HJ, Hung HC, Yang JL, Huang CS, Tsauo JY. Could Kinesio tape replace the bandage in decongestive lymphatic therapy for breast-cancer-related lymphedema? A pilot study. Support Care Cancer 2009;17(11):1353- 60.
12.Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a threeyear follow-up study. QJM 2005;98(5):343-8.
13.Bani HA, Fasching PA, Lux MM, Rauh C, Willner M, Eder I, et al. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 2007;66(3):311-8.
14.Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 2008;17(11):1450-9.
15.Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl) 2002;11(4):254-61.16. Tretbar LL, Morgan CL, Byung-Boong L, Simonian SJ, Blondeau B. Lymphedema. London: Springer; 2008.
17.Chang CJ, Cormier JN. Lymphedema interventions: exercise, surgery, and compression devices. Semin Oncol Nurs 2013;29(1):28-40.
18.Lasinski BB. Complete decongestive therapy for treatment of lymphedema. Semin Oncol Nurs 2013;29(1):20-7.
19.International Lymphoedema Framework: An International Perspective. International Consensus Best practice for the management of lymphoedema. Skin Care and Cellulitis/Erysipelas; 2006. p. 24-9.
20.Oremus M, Walker K, Dayes I, Raina P. Diagnosis and treatment of secondary lymphedema. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010. 21.Ridner SH. Pathophysiology of lymphedema. Semin Oncol Nurs 2013;29(1):4-11.
22.Gloviczki P. Handbook of venous disorders. Guidelines of the American Venous Forum. London: Edward Arnold; 2009.
23.Burns T, Breathnach S, Cox N, Griffiths C. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010.
24.Singh N. Radioisotopes-Applications in Bio-Medical Science. Intech Open Access Publisher; 2011. 25.Burgdorf WHC, Plewig G, Wolff HH, Landthaler M. Braun-Falco's Dermatology. Heidelberg: Springer; 2009.
26.Bernas M. Assessment and risk reduction in lymphedema. Semin Oncol Nurs 2013;29(1):12-9.
27.International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 2003;36(2):84-91.
28.International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology. Lymphology 2009;42(2):51-60.
29.Lee BB, Bergan J, Rockson SG. Lymphedema: a concise compendium of theory and practice. Springer Science & Business Media; 2011.
30.Özaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J of Surg 2004;187:69-72.
31.Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 2011;81(4):907-14.
32.DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14(6):500-15.
33.Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2010;16(1):48-54.
34.Das N, Baumgartner RN, Riley EC, Pinkston CM, Yang D, Baumgartner KB. Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. J Cancer Surviv 2015;9(3):422-30. 35.Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer 2004;41(1):8-12.
36.Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 2006;24(18):2765-72.
37.Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, et al. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 2009;113(2):383-91.
38.Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study. Breast Cancer Res Treat 2011;130(3):981-91.
39.Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007;16(4):775-82.
40.Wanchai A, Beck M, Stewart BR, Armer JM. Management of lymphedema for cancer patients with complex needs. Semin Oncol Nurs 2013;29(1):61-5.
41.Shahpar H, Atieh A, Maryam A, Fatemeh HS, Massoome N, Mandana E, et al. Risk factors of lymph edema in breast cancer patients. Int J Breast Cancer 2013;1-7.
42.Müezzinler NE, Karayurt Ö. Investigation of Experiences of Women Who Developed Lymphedema Related to Breast Cancer Treatment. J Breast Health 2014;10:23-9.
43.Sackey H, Magnuson A, Sandelin K, Liljegren G, Bergkvist L, Fülep Z, et al. Arm lymphoedema after axillary surgery in women with invasive breast cancer. Br J Surg 2014;101(4):390-97.
44.Maclellan RA, Greene AK. Lymphedema. Semin Pediatr Surg 2014;23(4):191-7.
45.Gary DE. Lymphedema diagnosis and management. J Am Acad Nurse Pract 2007;19(2):72-8.
46.Başaran S, Kozanoğlu E. Breast cancer related lymphedema and conservative therapies. Türk Fiz Tıp Rehab Derg 2009;55(1):30-5.
47.Földi E, Földi M. Lymphostatic Diseases. In: Földi, M., Földi, E. (Ed.), Földi's Textbook of Lymphology for Physicians and Lymphedema Therapists. 2nd edition. Munich, Mosby-Elsevier; 2006. p. 223-317.
48.Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med 1998;3(2):145-56.
49.Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin 2000;50(5):292-311.
50.Rodrick JR, Poage E, Wanchai A, Stewart BR, Cormier JN, Armer JM. Complementary, alternative, and other noncomplete decongestive therapy treatment methods in the management of lymphedema: a systematic search and review. PM R 2014;6(3):250-74.
51.Sayko O, Pezzin LE, Yen TW, Nattinger AB. Diagnosis and treatment of lymphedema after breast cancer: a population-based study. PM R 2013;5(11):915-23.
52.Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor ME, Thiadens SR. Lymphedema management. Semin Radiat Oncol 2003;13(3):290-301.
53.Cancer Australia. Clinical Best Practice/Lymphoedema Specialised treatment 2012. http://canceraustralia.gov.au/clinical-best-practice/lymphoedema/ gp-guides-and-resources/specialised-treatment. (Accessed: 01.02.2015).
54.Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012;4(8):580- 601.
55.Oremus M, Dayes I, Walker K, Raina P. Systematic review: conservative treatments for secondary lymphedema. BMC Cancer 2012;12(1):6.
56.Vignes S, Blanchard M, Arrault M, Porcher R. Intensive complete decongestive physiotherapy for cancerrelated upper-limb lymphedema: 11 days achieved greater volume reduction than 4. Gynecol Oncol 2013;131(1):127-30.
57.Bernas MJ, Witte CL, Witte MH. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. Lymphology 2001;34(2):84-91.
58.Asmussen PD, Strössenreuther RHK. Földi's Textbook of Lymphology for Physicians and Lymphedema Therapists. Mosby-Elsevier; 2006.
59.Olszewski WL. Contractility patterns of normal and pathologically changed human lymphatics. Ann N Y Acad Sci 2002;979:52-63; discussion 76-9.
60.Zuther JE, Norton S. Lymphedema Management. Stuttgart New York: Thieme; 2013.
61.Pain SJ, Purushotham AD. Lymphoedema following surgery for breast cancer. Br J Surg 2000;87(9):1128- 41.
62.Holcomb SS. Identification and treatment of different types of lymphedema. Adv Skin Wound Care 2006;19(2):103-10.
63.Cheville AL. Current and future trends in lymphedema management: implications for women's health. Phys Med Rehabil Clin N Am 2007;18(3):539-53.
64.Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens MR. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010;149(1):3-9.
65.McLaughlin SA. Lymphedema: Separating Fact From Fiction. Oncology 2012;26(3):242-9.
66.Olszewski WL, Engeset A. Studies on the lymphatic circulation of humans. In M. G. Johnston (Ed.), Experimental Biology of the Lymphatic Circulation, Amsterdam: Elsevier Science Publishers; 1985. p. 395- 422.
67.Havas E, Parviainen T, Vuorela J, Toivanen J, Nikula T, Vihko V. Lymph flow dynamics in exercising human skeletal muscle as detected by scintography. J Physiol 1997;504 (Pt 1):233-9.
68.Havas E, Lehtonen M, Vuorela J, Parviainen T, Vihko V. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000;85(6):863-8.
69.Johansson K. Is physiotherapy useful to the breast cancer patient? Acta Oncol 2005;44(5):423-4.
70.Földi M, Földi E, Kubik S. Textbook of lymphology for physicians and lymphedema therapists. Urgan & Fischer Verlag (Elsevier); 2003.
71.Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol 2008;26(35):5689-96.
72.Gürsoy AA. Meme kanseri tedavisine bağlı lenfö- dem ve hemşirelik bakımı. Cumhuriyet Üniversitesi Hemşirelik Yüksekokulu Dergisi 2005;9(2):18-25.
73.Hull MM. Lymphedema in women treated for breast cancer. Semin Oncol Nurs 2000;16(3):226-37.
74.Jennings-Sanders A, Kuo YF, Anderson ET, Freeman JL. How do nurse case managers care for older women with breast cancer? Oncol Nurs Forum 2005;32(3):625-32.
75.Hemşirelik Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik (2011). T. C. Resmi Gazete, 27910, 19 Nisan 2011.
76.Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg 2011;213(4):543-51.
77.Uzkeser H. Assessment of postmastectomy lymphedema and current treatment approaches. Eur J Gen Med 2012;9(2):130-34.

ISSN: 1300-7467
Başlangıç: 2015
Yayıncı: Ali Cangül

Arşiv